Evidence map›Paper›PMID 33118211›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling.

Wenguang Liu, Meng Feng, Chathuraka T Jayasuriya, Hang Peng, Long Zhang, Yingjie Guan, John A Froehlich, Richard M Terek, Qian Chen

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Healthcare and Scientific Treatment of Knee Osteoarthritis.Journal of healthcare engineering · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Wenguang LiuFrontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, China.
Meng FengDepartment of Orthopedics, Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI, USA.
Chathuraka T JayasuriyaDepartment of Orthopedics, Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI, USA.
Hang PengFrontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, China.
Long ZhangFrontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, China.
Yingjie GuanDepartment of Orthopedics, Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI, USA.
John A FroehlichDepartment of Orthopedics, Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI, USA.
Richard M TerekDepartment of Orthopedics, Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI, USA.
Qian ChenDepartment of Orthopedics, Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI, USA.
Brown University · USRhode Island Hospital · USXi'an Jiaotong University · CN

Funding

Pilot Projects ProgramP30GM122732 · NIGMS · RHODE ISLAND HOSPITAL · PI CRISCO, JOSEPH J · 2017 to 2021
$6.6M
Targeting CXCR4 and microRNA as Therapy for ChondrosarcomaR01CA166089 · NCI · RHODE ISLAND HOSPITAL · PI TEREK, RICHARD M · 2013 to 2017
$1.4M
Repressing Retrotransposon LINE-1: New Concepts for Osteoarthritis TreatmentR61AR076807 · NIAMS · RHODE ISLAND HOSPITAL · PI CHEN, QIAN · 2019 to 2020
$1.2M
HHS | NIH | National Cancer Institute (NCI) R01CA166089HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1R61AR076807-01HHS | NIH | National Institute of General Medical Sciences (NIGMS) P30GM122732NCI NIH HHS R01 CA166089NIAMS NIH HHS R61 AR076807NIGMS NIH HHS P30 GM122732
6 · The paper itself

Abstract

Human osteoarthritis cartilage contains chondrocytes (OAC) and mesenchymal stromal cells (OA-MSC). Here, we found that TGF-β had different effects on OA-MSC and OAC, and revealed its lateral signaling mechanism in OA. RNAseq analysis indicated that OA-MSC expressed the same level of Bone Morphogenetic Protein (BMP) Receptor-1A as OAC but only 1/12 of Transforming Growth Factor beta (TGF-β) Receptor-1. While TGF-β specifically activated SMAD2 in OAC, it also activated BMP signaling-associated SMAD1 in OA-MSC. While TGF-β stimulated chondrogenesis in OAC, it induced hypertrophy, mineralization, and MMP-13 in OA-MSC. Inhibiting TGF-βR1 suppressed MMP-13 in OA-MSC but stimulated it in OAC. In contrast, by specifically targeting BMPR1A/ACVR1 in both cell types, LDN193189 inhibits cartilage degeneration through suppressing hypertrophy and MMP-13 in a mouse osteoarthritis model. Thus, LDN193189, a drug under development to inhibit constitutive BMP signaling during heterotopic ossification, may be re-purposed for OA treatment.

Indexed as

AnimalsCartilage, ArticularCells, CulturedChondrocytesChondrogenesisHumansHypertrophyMaleMesenchymal Stem CellsMiceMice, Inbred C57BLOsteoarthritisReceptor, Transforming Growth Factor-beta Type ISignal TransductionSmad2 ProteinTransforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ISmad2 ProteinTransforming Growth Factor betacartilagemesenchymal stem cellsosteoarthritisTGF-beta

Identifiers

PMID33118211
PMCPMC8219090
OpenAlexW3095895348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.